A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

HXN-1001 is a half-life extended next-generation anti-TL1A antibody with great potential for the treatment of patients with inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's ...

Sarilumab treatment with a rapid glucocorticoid taper in relapsing polymyalgia rheumatica shows greater improvements in ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

Jasper Therapeutics is halving its workforce as part of cost-cutting measures aimed at extending the clinical-stage biotechnology company's runway on the heels of a clinical setback with its lead drug ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

The trial is spearheaded by Dr Jonathan Hernandez, the surgical oncology section chief of the National Cancer Institute.

The team is "here to stay," no matter what, lead researcher Keith Bowers said, amid federal funding changes for scientific ...